Skip to main content
Earnings Labs
Candel Therapeutics, Inc. logo

Candel Therapeutics, Inc. (CADL)

NASDAQ·Healthcare·Biotechnology

$8.52

+4.35%

Mkt Cap $467.21M

Analyst Ratings

Buy

3

Hold

0

Sell

0

Price Target (1 analysts)

$15.00

Range $15.00$15.00

Implied Upside

+76.2%

Consensus $15.00 vs current $8.52